Credit Suisse Reiterates Underperform Rating on Inflarx NV (IFRX) Despite FDA EUA
Tweet Send to a Friend
Credit Suisse analyst Tiago Fauth reiterated an Underperform rating and $2.00 price target on Inflarx NV (NASDAQ: IFRX) despite news ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
